Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.
Tang T, Abbott S, le Roux CW, Wilson V, Singhal R, Bellary S, Tahrani AA. Tang T, et al. Among authors: tahrani aa. Diabetes Obes Metab. 2018 Mar;20(3):745-748. doi: 10.1111/dom.13131. Epub 2017 Nov 22. Diabetes Obes Metab. 2018. PMID: 29053203
Emerging treatment options for type 2 diabetes.
Piya MK, Tahrani AA, Barnett AH. Piya MK, et al. Among authors: tahrani aa. Br J Clin Pharmacol. 2010 Nov;70(5):631-44. doi: 10.1111/j.1365-2125.2010.03711.x. Br J Clin Pharmacol. 2010. PMID: 20831513 Free PMC article. Review.
SGLT inhibitors in management of diabetes.
Tahrani AA, Barnett AH, Bailey CJ. Tahrani AA, et al. Lancet Diabetes Endocrinol. 2013 Oct;1(2):140-51. doi: 10.1016/S2213-8587(13)70050-0. Epub 2013 Aug 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622320 Review.
Novel therapeutics for type 2 diabetes: insulin resistance.
Altaf QA, Barnett AH, Tahrani AA. Altaf QA, et al. Among authors: tahrani aa. Diabetes Obes Metab. 2015 Apr;17(4):319-34. doi: 10.1111/dom.12400. Epub 2014 Nov 12. Diabetes Obes Metab. 2015. PMID: 25308775 Review.
Future glucose-lowering drugs for type 2 diabetes.
Bailey CJ, Tahrani AA, Barnett AH. Bailey CJ, et al. Among authors: tahrani aa. Lancet Diabetes Endocrinol. 2016 Apr;4(4):350-9. doi: 10.1016/S2213-8587(15)00462-3. Epub 2016 Jan 23. Lancet Diabetes Endocrinol. 2016. PMID: 26809680 Review.
189 results